Unraveling Human Herpesviruses: From Molecular Mechanisms to Antiviral Approaches
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 2
Special Issue Editor
Special Issue Information
Dear Colleagues,
Herpesviruses are large, enveloped, double-stranded DNA viruses that can cause illness ranging from cold sores to cancer. The Herpesviridae family comprises three subfamilies (alpha, beta, and gamma) that produce both latent and lytic infections. There are nine herpesviruses known to infect humans: Herpes Simplex Viruses 1 and 2, Varicella-Zoster Virus, Human Cytomegalovirus, Human Herpesvirus 6A and 6B, Human Herpesvirus 7, Epstein–Barr Virus, and Kaposi's Sarcoma-Associated Herpesvirus. Human herpesviruses infect the vast majority of the human population. While much progress has been made, there is still much research required to elucidate molecular mechanisms and develop effective therapies. This Special Issue focuses on recent advances in molecular-level processes and interactions involving human herpesviral activity and treatment strategies. I invite you to submit novel research on topics such as the post-translational and epigenetic regulation of these herpesviruses, as well as advances in antiviral and vaccine development.
Dr. Christopher B. Whitehurst
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human herpesviruses
- post-translational modifications
- epigenetics
- cancer
- molecular mechanisms
- antivirals
- protein interactions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
